Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ANDA Yo-Yo: FDA Receives Second-Lowest Submission Count In October After September Bolus
Dec 14 2024
•
By
Derrick Gingery
ANDA submissions dropped dramatically from a 140 in September to 14 in October.
(Shutterstock)
More from Generics
More from Pathways & Standards